Learn how machine learning and digital microscopy come together as an innovative method for studying phenotypic response of individual live cells and microcolonies.
Creating. Innovating. Collaborating. We move quickly at Accelerate by removing much of the bureaucracy that can stifle progress. Experience what its like to work here and see current career opportunities.
Presentations & Press Releases
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Jack Phillips has been appointed Chief Operating Officer. Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading...
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2019. "We achieved mixed results in the second quarter, as revenue and...
Accelerate Diagnostics, Inc. announced the release and CE marking of its latest Accelerate PhenoTest™ BC kit, declaring conformity to the European Directive 98/79/EC on in vitro diagnostic...
View all press releases
View all events
Join our mailing list
39th Annual William Blair Growth Stock Conference
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.
No thanks. Please take me back.